APO Research

APO RESEARCH · REPORT

Life Sciences Transactions Service

Selected research

Market Structure

Global Life Sciences Transactions Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Life Sciences Transactions Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Life Sciences Transactions Service include A&L Goodbody, Arnold & Porter, Baker McKenzie, Covington, DLA Piper, HaysMac, Holland & Knight, Kirkland & Ellis LLP and L.E.K. Consulting, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Life Sciences Transactions Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Life Sciences Transactions Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Life Sciences Transactions Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Life Sciences Transactions Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Life Sciences Transactions Service Segment by Company

A&L Goodbody

Arnold & Porter

Baker McKenzie

Covington

DLA Piper

HaysMac

Holland & Knight

Kirkland & Ellis LLP

L.E.K. Consulting

Morgan Lewis

Osborne Clarke

Pharma Bio Source

Pinnacle

Reed Smith LLP

RNA Advisors

Sidley Austin

Tenthpin

Troutman Pepper Locke

WilmerHale

Life Sciences Transactions Service Segment by Type

Intellectual Property Licensing Transactions

Product Asset Transactions

Equity Mergers and Acquisitions

Other

Life Sciences Transactions Service Segment by Application

Biopharmaceuticals and Innovative Therapies

Medical Devices and Diagnostics

Contract Research, Development, and Manufacturing Organizations

Digital Health and Healthcare Services

Others

Life Sciences Transactions Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Sciences Transactions Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Life Sciences Transactions Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Sciences Transactions Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Life Sciences Transactions Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life Sciences Transactions Service industry.

Chapter 3: Detailed analysis of Life Sciences Transactions Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Life Sciences Transactions Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Life Sciences Transactions Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Intellectual Property Licensing Transactions Table 3. Key Players of Product Asset Transactions Table 4. Key Players of Equity Mergers and Acquisitions Table 3. Key Players of Other Table 4. Global Life Sciences Transactions Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biopharmaceuticals and Innovative Therapies Table 6. Key Players of Medical Devices and Diagnostics Table 7. Key Players of Contract Research, Development, and Manufacturing Organizations Table 8. Key Players of Digital Health and Healthcare Services Table 9. Key Players of Others Table 10. Global Life Sciences Transactions Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Life Sciences Transactions Service Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Life Sciences Transactions Service Market Share by Region (2021-2026) Table 13. Global Life Sciences Transactions Service Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Life Sciences Transactions Service Market Share by Region (2027-2032) Table 15. Life Sciences Transactions Service Industry Trends Table 16. Life Sciences Transactions Service Industry Drivers Table 17. Life Sciences Transactions Service Industry Opportunities and Challenges Table 18. Life Sciences Transactions Service Industry Restraints Table 19. Global Life Sciences Transactions Service Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Life Sciences Transactions Service Revenue Market Share by Company (2021-2026) Table 21. Global Life Sciences Transactions Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Life Sciences Transactions Service Key Company Head Office and Area Served Table 23. Global Life Sciences Transactions Service Company, Product Type & Application Table 24. Global Life Sciences Transactions Service Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Life Sciences Transactions Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Life Sciences Transactions Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Life Sciences Transactions Service Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Life Sciences Transactions Service Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Life Sciences Transactions Service Revenue Market Share by Type (2021-2026) Table 31. Global Life Sciences Transactions Service Revenue Market Share by Type (2027-2032) Table 32. Global Life Sciences Transactions Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Life Sciences Transactions Service Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Life Sciences Transactions Service Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Life Sciences Transactions Service Revenue Market Share by Application (2021-2026) Table 36. Global Life Sciences Transactions Service Revenue Market Share by Application (2027-2032) Table 37. A&L Goodbody Company Information Table 38. A&L Goodbody Business Overview Table 39. A&L Goodbody Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. A&L Goodbody Life Sciences Transactions Service Product Portfolio Table 41. A&L Goodbody Recent Development Table 42. Arnold & Porter Company Information Table 43. Arnold & Porter Business Overview Table 44. Arnold & Porter Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Arnold & Porter Life Sciences Transactions Service Product Portfolio Table 46. Arnold & Porter Recent Development Table 47. Baker McKenzie Company Information Table 48. Baker McKenzie Business Overview Table 49. Baker McKenzie Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Baker McKenzie Life Sciences Transactions Service Product Portfolio Table 51. Baker McKenzie Recent Development Table 52. Covington Company Information Table 53. Covington Business Overview Table 54. Covington Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Covington Life Sciences Transactions Service Product Portfolio Table 56. Covington Recent Development Table 57. DLA Piper Company Information Table 58. DLA Piper Business Overview Table 59. DLA Piper Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. DLA Piper Life Sciences Transactions Service Product Portfolio Table 61. DLA Piper Recent Development Table 62. HaysMac Company Information Table 63. HaysMac Business Overview Table 64. HaysMac Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. HaysMac Life Sciences Transactions Service Product Portfolio Table 66. HaysMac Recent Development Table 67. Holland & Knight Company Information Table 68. Holland & Knight Business Overview Table 69. Holland & Knight Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Holland & Knight Life Sciences Transactions Service Product Portfolio Table 71. Holland & Knight Recent Development Table 72. Kirkland & Ellis LLP Company Information Table 73. Kirkland & Ellis LLP Business Overview Table 74. Kirkland & Ellis LLP Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Kirkland & Ellis LLP Life Sciences Transactions Service Product Portfolio Table 76. Kirkland & Ellis LLP Recent Development Table 77. L.E.K. Consulting Company Information Table 78. L.E.K. Consulting Business Overview Table 79. L.E.K. Consulting Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. L.E.K. Consulting Life Sciences Transactions Service Product Portfolio Table 81. L.E.K. Consulting Recent Development Table 82. Morgan Lewis Company Information Table 83. Morgan Lewis Business Overview Table 84. Morgan Lewis Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Morgan Lewis Life Sciences Transactions Service Product Portfolio Table 86. Morgan Lewis Recent Development Table 87. Osborne Clarke Company Information Table 88. Osborne Clarke Business Overview Table 89. Osborne Clarke Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Osborne Clarke Life Sciences Transactions Service Product Portfolio Table 91. Osborne Clarke Recent Development Table 92. Pharma Bio Source Company Information Table 93. Pharma Bio Source Business Overview Table 94. Pharma Bio Source Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Pharma Bio Source Life Sciences Transactions Service Product Portfolio Table 96. Pharma Bio Source Recent Development Table 97. Pinnacle Company Information Table 98. Pinnacle Business Overview Table 99. Pinnacle Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Pinnacle Life Sciences Transactions Service Product Portfolio Table 101. Pinnacle Recent Development Table 102. Reed Smith LLP Company Information Table 103. Reed Smith LLP Business Overview Table 104. Reed Smith LLP Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Reed Smith LLP Life Sciences Transactions Service Product Portfolio Table 106. Reed Smith LLP Recent Development Table 107. RNA Advisors Company Information Table 108. RNA Advisors Business Overview Table 109. RNA Advisors Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. RNA Advisors Life Sciences Transactions Service Product Portfolio Table 111. RNA Advisors Recent Development Table 112. Sidley Austin Company Information Table 113. Sidley Austin Business Overview Table 114. Sidley Austin Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Sidley Austin Life Sciences Transactions Service Product Portfolio Table 116. Sidley Austin Recent Development Table 117. Tenthpin Company Information Table 118. Tenthpin Business Overview Table 119. Tenthpin Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Tenthpin Life Sciences Transactions Service Product Portfolio Table 121. Tenthpin Recent Development Table 122. Troutman Pepper Locke Company Information Table 123. Troutman Pepper Locke Business Overview Table 124. Troutman Pepper Locke Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Troutman Pepper Locke Life Sciences Transactions Service Product Portfolio Table 126. Troutman Pepper Locke Recent Development Table 127. WilmerHale Company Information Table 128. WilmerHale Business Overview Table 129. WilmerHale Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. WilmerHale Life Sciences Transactions Service Product Portfolio Table 131. WilmerHale Recent Development Table 132. North America Life Sciences Transactions Service Market Size by Type (2021-2026) & (US$ Million) Table 133. North America Life Sciences Transactions Service Market Size by Type (2027-2032) & (US$ Million) Table 134. North America Life Sciences Transactions Service Market Size by Application (2021-2026) & (US$ Million) Table 135. North America Life Sciences Transactions Service Market Size by Application (2027-2032) & (US$ Million) Table 136. North America Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Life Sciences Transactions Service Market Size by Country (2021-2026) Table 138. North America Life Sciences Transactions Service Market Size by Country (2027-2032) Table 139. Europe Life Sciences Transactions Service Market Size by Type (2021-2026) & (US$ Million) Table 140. Europe Life Sciences Transactions Service Market Size by Type (2027-2032) & (US$ Million) Table 141. Europe Life Sciences Transactions Service Market Size by Application (2021-2026) & (US$ Million) Table 142. Europe Life Sciences Transactions Service Market Size by Application (2027-2032) & (US$ Million) Table 143. Europe Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Life Sciences Transactions Service Market Size by Country (2021-2026) Table 145. Europe Life Sciences Transactions Service Market Size by Country (2027-2032) Table 146. China Life Sciences Transactions Service Market Size by Type (2021-2026) & (US$ Million) Table 147. China Life Sciences Transactions Service Market Size by Type (2027-2032) & (US$ Million) Table 148. China Life Sciences Transactions Service Market Size by Application (2021-2026) & (US$ Million) Table 149. China Life Sciences Transactions Service Market Size by Application (2027-2032) & (US$ Million) Table 150. Asia Life Sciences Transactions Service Market Size by Type (2021-2026) & (US$ Million) Table 151. Asia Life Sciences Transactions Service Market Size by Type (2027-2032) & (US$ Million) Table 152. Asia Life Sciences Transactions Service Market Size by Application (2021-2026) & (US$ Million) Table 153. Asia Life Sciences Transactions Service Market Size by Application (2027-2032) & (US$ Million) Table 154. Asia Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Life Sciences Transactions Service Market Size by Country (2021-2026) Table 156. Asia Life Sciences Transactions Service Market Size by Country (2027-2032) Table 157. South America, Middle East & Africa Life Sciences Transactions Service Market Size by Type (2021-2026) & (US$ Million) Table 158. South America, Middle East & Africa Life Sciences Transactions Service Market Size by Type (2027-2032) & (US$ Million) Table 159. South America, Middle East & Africa Life Sciences Transactions Service Market Size by Application (2021-2026) & (US$ Million) Table 160. South America, Middle East & Africa Life Sciences Transactions Service Market Size by Application (2027-2032) & (US$ Million) Table 161. South America, Middle East & Africa Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. South America, Middle East & Africa Life Sciences Transactions Service Market Size by Country (2021-2026) Table 163. South America, Middle East & Africa Life Sciences Transactions Service Market Size by Country (2027-2032) Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Life Sciences Transactions Service Product Image Figure 2. Global Life Sciences Transactions Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Life Sciences Transactions Service Market Share by Type: 2025 VS 2032 Figure 4. Intellectual Property Licensing Transactions Image Figure 5. Product Asset Transactions Image Figure 6. Equity Mergers and Acquisitions Image Figure 7. Other Image Figure 8. Global Life Sciences Transactions Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Life Sciences Transactions Service Market Share by Application: 2025 VS 2032 Figure 10. Biopharmaceuticals and Innovative Therapies Image Figure 11. Medical Devices and Diagnostics Image Figure 12. Contract Research, Development, and Manufacturing Organizations Image Figure 13. Digital Health and Healthcare Services Image Figure 14. Others Image Figure 15. Global Life Sciences Transactions Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 17. Global Life Sciences Transactions Service Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Life Sciences Transactions Service Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Life Sciences Transactions Service Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Life Sciences Transactions Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Life Sciences Transactions Service Revenue Market Share by Type (2021-2032) Figure 24. Global Life Sciences Transactions Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Life Sciences Transactions Service Revenue Market Share by Application (2021-2032) Figure 26. North America Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 27. North America Life Sciences Transactions Service Market Share by Type (2021-2032) Figure 28. North America Life Sciences Transactions Service Market Share by Application (2021-2032) Figure 29. North America Life Sciences Transactions Service Market Share by Country (2021-2032) Figure 30. United States Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 31. Canada Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 34. Europe Life Sciences Transactions Service Market Share by Type (2021-2032) Figure 35. Europe Life Sciences Transactions Service Market Share by Application (2021-2032) Figure 36. Europe Life Sciences Transactions Service Market Share by Country (2021-2032) Figure 37. Germany Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 38. France Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 40. Italy Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 41. Russia Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 43. China Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 44. China Life Sciences Transactions Service Market Share by Type (2021-2032) Figure 45. China Life Sciences Transactions Service Market Share by Application (2021-2032) Figure 46. Asia Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 47. Asia Life Sciences Transactions Service Market Share by Type (2021-2032) Figure 48. Asia Life Sciences Transactions Service Market Share by Application (2021-2032) Figure 49. Asia Life Sciences Transactions Service Market Share by Country (2021-2032) Figure 50. Japan Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 54. India Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 55. Australia Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Life Sciences Transactions Service Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Life Sciences Transactions Service Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Life Sciences Transactions Service Market Share by Country (2021-2032) Figure 60. Brazil Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 65. UAE Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 67. Chile Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intellectual Property Licensing Transactions
  • Product Asset Transactions
  • Equity Mergers and Acquisitions
  • Other
Applications
  • Biopharmaceuticals and Innovative Therapies
  • Medical Devices and Diagnostics
  • Contract Research, Development, and Manufacturing Organizations
  • Digital Health and Healthcare Services
  • Others
Companies covered
  • A&L Goodbody
  • Arnold & Porter
  • Baker McKenzie
  • Covington
  • DLA Piper
  • HaysMac
  • Holland & Knight
  • Kirkland & Ellis LLP
  • L.E.K. Consulting
  • Morgan Lewis
  • Osborne Clarke
  • Pharma Bio Source
  • Pinnacle
  • Reed Smith LLP
  • RNA Advisors
  • Sidley Austin
  • Tenthpin
  • Troutman Pepper Locke
  • WilmerHale

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Life Sciences Transactions Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Intellectual Property Licensing Transactions
  5. 1.2.3 Product Asset Transactions
  6. 1.2.4 Equity Mergers and Acquisitions
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Life Sciences Transactions Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Biopharmaceuticals and Innovative Therapies
  11. 1.3.3 Medical Devices and Diagnostics
  12. 1.3.4 Contract Research, Development, and Manufacturing Organizations
  13. 1.3.5 Digital Health and Healthcare Services
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Life Sciences Transactions Service Growth Trends by Region
  17. 1.5.1 Global Life Sciences Transactions Service Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Life Sciences Transactions Service Market Size by Region (2021-2026)
  19. 1.5.3 Life Sciences Transactions Service Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Life Sciences Transactions Service Market Dynamics
  1. 2.1 Life Sciences Transactions Service Industry Trends
  2. 2.2 Life Sciences Transactions Service Industry Drivers
  3. 2.3 Life Sciences Transactions Service Industry Opportunities and Challenges
  4. 2.4 Life Sciences Transactions Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Life Sciences Transactions Service Revenue by Company (2021-2026)
  2. 3.2 Global Life Sciences Transactions Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Life Sciences Transactions Service Key Company Head office and Area Served
  4. 3.4 Global Life Sciences Transactions Service Company, Product Type & Application
  5. 3.5 Global Life Sciences Transactions Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Life Sciences Transactions Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Life Sciences Transactions Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Life Sciences Transactions Service Tier 1, Tier 2, and Tier 3
4 Life Sciences Transactions Service Market by Type
  1. 4.1 Global Life Sciences Transactions Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Life Sciences Transactions Service Market Size by Type (2021-2032)
  3. 4.3 Global Life Sciences Transactions Service Market Size Share by Type (2021-2032)
5 Life Sciences Transactions Service Market by Application
  1. 5.1 Global Life Sciences Transactions Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Life Sciences Transactions Service Market Size by Application (2021-2032)
  3. 5.3 Global Life Sciences Transactions Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 A&L Goodbody
  2. 6.1.1 A&L Goodbody Company Information
  3. 6.1.2 A&L Goodbody Business Overview
  4. 6.1.3 A&L Goodbody Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 A&L Goodbody Life Sciences Transactions Service Product Portfolio
  6. 6.1.5 A&L Goodbody Recent Developments
  7. 6.2 Arnold & Porter
  8. 6.2.1 Arnold & Porter Company Information
  9. 6.2.2 Arnold & Porter Business Overview
  10. 6.2.3 Arnold & Porter Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Arnold & Porter Life Sciences Transactions Service Product Portfolio
  12. 6.2.5 Arnold & Porter Recent Developments
  13. 6.3 Baker McKenzie
  14. 6.3.1 Baker McKenzie Company Information
  15. 6.3.2 Baker McKenzie Business Overview
  16. 6.3.3 Baker McKenzie Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Baker McKenzie Life Sciences Transactions Service Product Portfolio
  18. 6.3.5 Baker McKenzie Recent Developments
  19. 6.4 Covington
  20. 6.4.1 Covington Company Information
  21. 6.4.2 Covington Business Overview
  22. 6.4.3 Covington Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Covington Life Sciences Transactions Service Product Portfolio
  24. 6.4.5 Covington Recent Developments
  25. 6.5 DLA Piper
  26. 6.5.1 DLA Piper Company Information
  27. 6.5.2 DLA Piper Business Overview
  28. 6.5.3 DLA Piper Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 DLA Piper Life Sciences Transactions Service Product Portfolio
  30. 6.5.5 DLA Piper Recent Developments
  31. 6.6 HaysMac
  32. 6.6.1 HaysMac Company Information
  33. 6.6.2 HaysMac Business Overview
  34. 6.6.3 HaysMac Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 HaysMac Life Sciences Transactions Service Product Portfolio
  36. 6.6.5 HaysMac Recent Developments
  37. 6.7 Holland & Knight
  38. 6.7.1 Holland & Knight Company Information
  39. 6.7.2 Holland & Knight Business Overview
  40. 6.7.3 Holland & Knight Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Holland & Knight Life Sciences Transactions Service Product Portfolio
  42. 6.7.5 Holland & Knight Recent Developments
  43. 6.8 Kirkland & Ellis LLP
  44. 6.8.1 Kirkland & Ellis LLP Company Information
  45. 6.8.2 Kirkland & Ellis LLP Business Overview
  46. 6.8.3 Kirkland & Ellis LLP Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Kirkland & Ellis LLP Life Sciences Transactions Service Product Portfolio
  48. 6.8.5 Kirkland & Ellis LLP Recent Developments
  49. 6.9 L.E.K. Consulting
  50. 6.9.1 L.E.K. Consulting Company Information
  51. 6.9.2 L.E.K. Consulting Business Overview
  52. 6.9.3 L.E.K. Consulting Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 L.E.K. Consulting Life Sciences Transactions Service Product Portfolio
  54. 6.9.5 L.E.K. Consulting Recent Developments
  55. 6.10 Morgan Lewis
  56. 6.10.1 Morgan Lewis Company Information
  57. 6.10.2 Morgan Lewis Business Overview
  58. 6.10.3 Morgan Lewis Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Morgan Lewis Life Sciences Transactions Service Product Portfolio
  60. 6.10.5 Morgan Lewis Recent Developments
  61. 6.11 Osborne Clarke
  62. 6.11.1 Osborne Clarke Company Information
  63. 6.11.2 Osborne Clarke Business Overview
  64. 6.11.3 Osborne Clarke Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Osborne Clarke Life Sciences Transactions Service Product Portfolio
  66. 6.11.5 Osborne Clarke Recent Developments
  67. 6.12 Pharma Bio Source
  68. 6.12.1 Pharma Bio Source Company Information
  69. 6.12.2 Pharma Bio Source Business Overview
  70. 6.12.3 Pharma Bio Source Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Pharma Bio Source Life Sciences Transactions Service Product Portfolio
  72. 6.12.5 Pharma Bio Source Recent Developments
  73. 6.13 Pinnacle
  74. 6.13.1 Pinnacle Company Information
  75. 6.13.2 Pinnacle Business Overview
  76. 6.13.3 Pinnacle Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Pinnacle Life Sciences Transactions Service Product Portfolio
  78. 6.13.5 Pinnacle Recent Developments
  79. 6.14 Reed Smith LLP
  80. 6.14.1 Reed Smith LLP Company Information
  81. 6.14.2 Reed Smith LLP Business Overview
  82. 6.14.3 Reed Smith LLP Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Reed Smith LLP Life Sciences Transactions Service Product Portfolio
  84. 6.14.5 Reed Smith LLP Recent Developments
  85. 6.15 RNA Advisors
  86. 6.15.1 RNA Advisors Company Information
  87. 6.15.2 RNA Advisors Business Overview
  88. 6.15.3 RNA Advisors Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 RNA Advisors Life Sciences Transactions Service Product Portfolio
  90. 6.15.5 RNA Advisors Recent Developments
  91. 6.16 Sidley Austin
  92. 6.16.1 Sidley Austin Company Information
  93. 6.16.2 Sidley Austin Business Overview
  94. 6.16.3 Sidley Austin Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Sidley Austin Life Sciences Transactions Service Product Portfolio
  96. 6.16.5 Sidley Austin Recent Developments
  97. 6.17 Tenthpin
  98. 6.17.1 Tenthpin Company Information
  99. 6.17.2 Tenthpin Business Overview
  100. 6.17.3 Tenthpin Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Tenthpin Life Sciences Transactions Service Product Portfolio
  102. 6.17.5 Tenthpin Recent Developments
  103. 6.18 Troutman Pepper Locke
  104. 6.18.1 Troutman Pepper Locke Company Information
  105. 6.18.2 Troutman Pepper Locke Business Overview
  106. 6.18.3 Troutman Pepper Locke Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Troutman Pepper Locke Life Sciences Transactions Service Product Portfolio
  108. 6.18.5 Troutman Pepper Locke Recent Developments
  109. 6.19 WilmerHale
  110. 6.19.1 WilmerHale Company Information
  111. 6.19.2 WilmerHale Business Overview
  112. 6.19.3 WilmerHale Life Sciences Transactions Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 WilmerHale Life Sciences Transactions Service Product Portfolio
  114. 6.19.5 WilmerHale Recent Developments
7 North America
  1. 7.1 North America Life Sciences Transactions Service Market Size (2021-2032)
  2. 7.2 North America Life Sciences Transactions Service Market Size by Type
  3. 7.2.1 North America Life Sciences Transactions Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Life Sciences Transactions Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Life Sciences Transactions Service Market Share by Type (2021-2032)
  6. 7.3 North America Life Sciences Transactions Service Market Size by Application
  7. 7.3.1 North America Life Sciences Transactions Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Life Sciences Transactions Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Life Sciences Transactions Service Market Share by Application (2021-2032)
  10. 7.4 North America Life Sciences Transactions Service Market Size by Country
  11. 7.4.1 North America Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Life Sciences Transactions Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Life Sciences Transactions Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Life Sciences Transactions Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Life Sciences Transactions Service Market Size (2021-2032)
  2. 8.2 Europe Life Sciences Transactions Service Market Size by Type
  3. 8.2.1 Europe Life Sciences Transactions Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Life Sciences Transactions Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Life Sciences Transactions Service Market Share by Type (2021-2032)
  6. 8.3 Europe Life Sciences Transactions Service Market Size by Application
  7. 8.3.1 Europe Life Sciences Transactions Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Life Sciences Transactions Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Life Sciences Transactions Service Market Share by Application (2021-2032)
  10. 8.4 Europe Life Sciences Transactions Service Market Size by Country
  11. 8.4.1 Europe Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Life Sciences Transactions Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Life Sciences Transactions Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Life Sciences Transactions Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Life Sciences Transactions Service Market Size (2021-2032)
  2. 9.2 China Life Sciences Transactions Service Market Size by Type
  3. 9.2.1 China Life Sciences Transactions Service Market Size by Type (2021-2026)
  4. 9.2.2 China Life Sciences Transactions Service Market Size by Type (2027-2032)
  5. 9.2.3 China Life Sciences Transactions Service Market Share by Type (2021-2032)
  6. 9.3 China Life Sciences Transactions Service Market Size by Application
  7. 9.3.1 China Life Sciences Transactions Service Market Size by Application (2021-2026)
  8. 9.3.2 China Life Sciences Transactions Service Market Size by Application (2027-2032)
  9. 9.3.3 China Life Sciences Transactions Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Life Sciences Transactions Service Market Size (2021-2032)
  2. 10.2 Asia Life Sciences Transactions Service Market Size by Type
  3. 10.2.1 Asia Life Sciences Transactions Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Life Sciences Transactions Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Life Sciences Transactions Service Market Share by Type (2021-2032)
  6. 10.3 Asia Life Sciences Transactions Service Market Size by Application
  7. 10.3.1 Asia Life Sciences Transactions Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Life Sciences Transactions Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Life Sciences Transactions Service Market Share by Application (2021-2032)
  10. 10.4 Asia Life Sciences Transactions Service Market Size by Country
  11. 10.4.1 Asia Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Life Sciences Transactions Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Life Sciences Transactions Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Life Sciences Transactions Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Life Sciences Transactions Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Life Sciences Transactions Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Life Sciences Transactions Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Life Sciences Transactions Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Life Sciences Transactions Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research